“The Impact of Tralokinumab on Quality of Life and School in Patients Aged 12–17 With Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s77, https://doi.org/10.25251/skin.6.supp.77.